← FDA DRUG APPROVALS

FDA NDA · NDA017672

LITHONATE

Sponsor: SOLVAY

APPLICATION
NDA017672
TYPE
NDA
ROUTE
ORAL
DOSAGE FORM
SYRUP
MARKETING STATUS
Discontinued

Products

LITHONATEDiscontinued
LITHIUM CITRATE EQ 300MG CARBONATE/5ML · SYRUP · ORAL
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →